Multiple imputation methodology is reflective of secukinumab efficacy in real clinical practice: Data from the FIXTURE and ERASURE studies in moderate to severe plaque psoriasis

被引：0

作者：

Langley, Richard ^{[1
]}

Reich, Kristian ^{[2
,3
]}

Papavassilis, Charms ^{[4
]}

Fox, Todd ^{[4
]}

Gong, Yankun ^{[5
]}

Guettner, Achim ^{[4
]}

机构：

[1] Dalhousie Univ, Halifax, NS, Canada

[2] Dermatologikum Hamburg, Hamburg, Germany

[3] SCIderm Res Inst, Hamburg, Germany

[4] Novartis Pharma AG, Basel, Switzerland

[5] Beijing Novartis Pharma Co Ltd, Shanghai, Peoples R China

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2015年 / 135卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P047

引用

页码：S13 / S13

页数：1

共 50 条

[1] Multiple imputation methodology is reflective of secukinumab efficacy in real clinical practice: data from the FIXTURE and ERASURE studies in moderate-to-severe plaque psoriasis
Langley, R. G.
Reich, K.
Papavassilis, C.
Fox, T.
Gong, Y.
Guettner, A.
BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E165 - E165
[2] Method of multiple Imputation confirms Efficacy of Secukinumab in practice: FIXTURE and ERASURE Data for moderate to severe Plaque-Psoriasis
Reich, K.
Langley, R. G.
Fox, T.
Gong, Y.
Guettner, A.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 142 - 142
[3] Secukinumab efficacy and safety in Asian subjects with moderate to severe plaque psoriasis: Pooled analysis from the FIXTURE and ERASURE phase III clinical studies
Lee, Jeung-Hoon
Morita, Akimichi
Tsai, Tsen-Fang
Zheng, Eugene
Ko, Luke
Fox, Todd
Langley, Richard
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB249 - AB249
[4] Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response and Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)
Elewski, B.
Lebwohl, M.
Papp, K.
Nakagawa, H.
Sigurgeirsson, B.
Tsai, T. -F.
Tyring, S.
Hampele, I.
Karpov, A.
Helou, S.
Papavassilis, C.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2014, 55 : 43 - 43
[5] Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response And Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)
Elewski, B.
Lebwohl, M.
Papp, K.
Nakagawa, H.
Sigurgeirsson, B.
Tsai, T.
Tyring, S.
Hampele, I.
Karpov, A.
Helou, S.
Papavassilis, C.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 15 - 15
[6] Secukinumab efficacy in subjects with moderate to severe plaque psoriasis: A pooled analysis of patient-reported symptoms (pruritus, pain, and scaling) in 2 phase 3 clinical studies (ERASURE and FIXTURE)
Reich, Kristian
Gottlieb, Alice
Loeffler, Juergen
Cooper, Simon
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB186 - AB186
[7] Secukinumab sustainability of response in subjects with moderate to severe plaque psoriasis: A subanalysis from the FIXTURE study
Reich, Kristian
Papavassilis, Charis
Puig, Luis
Notter, Marianne
Draelos, Zoe
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB188 - AB188
[8] Efficacy and safety of secukinumab in Taiwanese patients with moderate to severe plaque psoriasis: Subanalysis from ERASURE phase III study
Wu, Nan-Lin
Hsu, Chih-Jung
Sun, Fang-Ju
Tsai, Tsen-Fang
JOURNAL OF DERMATOLOGY, 2017, 44 (10): : 1129 - 1137
[9] Secukinumab efficacy in subjects with moderate-to-severe plaque psoriasis and concomitant psoriatic arthritis: A subanalysis of the ERASURE study
Blauvelt, Andrew
Gottlieb, Alice
Sigurgeirsson, Bardur
Papavassilis, Charis
Martin, Ruvie
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB2 - AB2
[10] Analysis of efficacy and safety of secukinumab in patients with moderate to severe psoriasis in clinical practice
Banos Arevalo, Antonio jose
Barranquero Fernandez, Alvaro
Herrera Acosta, Enrique
Suarez Perez, Jorge Alonso
Gonzalez Saavedra, Jose Andres
Herrera Ceballos, Enrique
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB43 - AB43

← 1 2 3 4 5 →